NCT00686296

Brief Summary

To evaluate wound healing with the use of Taliderm™ dressing and compare it to wet to dry dressing in the treatment of open wounds after incision and drainage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 29, 2008

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

March 17, 2015

Status Verified

March 1, 2015

Enrollment Period

2.3 years

First QC Date

May 26, 2008

Last Update Submit

March 16, 2015

Conditions

Keywords

soft tissue abscess requiring incision and drainage

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint of this study will be rate of wound healing (judged as per cent complete wound closure) at the two (2) and three (3) week follow-up visits.

    two and three weeks

Secondary Outcomes (1)

  • occurence of wound infection

    two and three weeks

Study Arms (3)

Group II

ACTIVE COMPARATOR

Taliderm™ dressing applied until the next scheduled dressing change (up to eight hours), then replaced by a gauze dressing. Gauze dressing changes will continue per standard of care until the scheduled follow-up visits (first or second visit). At the scheduled follow-up visits, the subject will have a Taliderm™ dressing applied and left in place until the next scheduled dressing change (up to eight hours), then will continue standard of care wet to dry gauze dressing changes until next scheduled follow-up visit.

Other: Taliderm™

III

OTHER

standard wet to dry dressing with gauze

Other: standard wet to dry dressing with gauze

group I

ACTIVE COMPARATOR

Taliderm™ dressing applied until the next scheduled dressing change (up to eight hours), then replaced by a gauze dressing

Other: Taliderm™

Interventions

taliderm™ dressing application once

group I

wet to dry dressing standard of care

III

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients with soft tissue abscess that will result in an open surgical wounds greater than or equal to 4 cms in any dimension
  • Wound will require serial dressing changes
  • Greater than or equal to 18 years of age
  • Ability to obtain informed consent

You may not qualify if:

  • Inability to obtain informed consent
  • Pregnancy
  • Prisoner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

San Antonio, Texas, 78229, United States

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • John G Myers, MD

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2008

First Posted

May 29, 2008

Study Start

December 1, 2008

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

March 17, 2015

Record last verified: 2015-03

Locations